Asset Details
Do you wish to reserve the book?
A Review of Neovascular Glaucoma: Etiology, Pathogenesis, Diagnosis, and Treatment
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A Review of Neovascular Glaucoma: Etiology, Pathogenesis, Diagnosis, and Treatment
Do you wish to request the book?
A Review of Neovascular Glaucoma: Etiology, Pathogenesis, Diagnosis, and Treatment
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
A Review of Neovascular Glaucoma: Etiology, Pathogenesis, Diagnosis, and Treatment
2022
Overview
Neovascular glaucoma (NVG) is a rare, aggressive, blinding secondary glaucoma, which is characterized by neovascularization of the anterior segment of the eye and leading to elevation of the intraocular pressure (IOP). The main etiological factor is retinal ischemia leading to an impaired homeostatic balance between the angiogenic and antiangiogenic factors. High concentrations of vasogenic substances such as vascular endothelial growth factor (VEGF) induce neovascularization of the iris (NVI) and neovascularization of the angle (NVA) that limits the outflow of aqueous humor from the anterior chamber and increases the IOP. NVG clinical, if untreated, progresses from secondary open-angle glaucoma to angle-closure glaucoma, leading to irreversible blindness. It is an urgent ophthalmic condition; early diagnosis and treatment are necessary to preserve vision and prevent eye loss. The management of NVG requires the cooperation of retinal and glaucoma specialists. The treatment of NVG includes both control of the underlying disease and management of IOP. The main goal is the prevention of angle-closure glaucoma by combining panretinal photocoagulation (PRP) and antiangiogenic therapy. The aim of this review is to summarize the current available knowledge about the etiology, pathogenesis, and symptoms of NVG and determine the most effective treatment methods.
Publisher
MDPI AG,MDPI
Subject
/ Causes and theories of causation
/ Diabetes
/ Disease
/ Diseases
/ Etiology
/ Glaucoma
/ Glaucoma, Angle-Closure - diagnosis
/ Glaucoma, Angle-Closure - etiology
/ Glaucoma, Angle-Closure - therapy
/ Glaucoma, Neovascular - diagnosis
/ Glaucoma, Neovascular - etiology
/ Glaucoma, Neovascular - therapy
/ Glaucoma, Open-Angle - diagnosis
/ Glaucoma, Open-Angle - etiology
/ Glaucoma, Open-Angle - therapy
/ Humans
/ intravitreal anti-VEGF therapy
/ Iris
/ Ischemia
/ Patients
/ Review
